Generic Name

Composition

Therapeutic Category

Division

Gentamicin

Gentamicin Sulphate 0.2% w/w Cream

Topical Antibiotic

TIME

    BRAND COMPOSITION DESCRIPTION
     GENTIME  Each tube contains:
    Gentamicin Sulphate IP           0.1% w/w
    White semisolid cream. 10 g of the cream filled in a collapsible aluminum tube.

     

    PATIENT INFORMATION

    Pregnancy:Category C

    Storage: Store between 2- 30°C

    Missed dose:If you forget to apply the cream, apply it as soon as you remember; If your next dose is due within an hour, skip the missed dose; Do not use a double dose to make up for a forgotten dose.

    PHARMACOLOGY

    Pharmacotherapeutic Group: Aminoglycoside Antibiotic

     Pharmacodynamic Properties:

    Gentamicin is a broad spectrum aminoglycoside antibiotic. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit, causing misreading of t-RNA, leaving the bacterium unable to synthesize proteins vital to its growth.

    Pharmacokinetic Properties:

    Absorption: Systemic absorption from denuded skin and burns (topical) and from wounds

    Distribution: Diffuse mainly into the extracellular fluids. Crosses the placenta and breast milk.

    Excretion: Via the urine by glomerular filtration virtually unchanged, elimination half life: 2-3 hr

     INDICATIONS

    Skin infections, burns and wounds, bone and soft tissue infections

     DOSAGE & ADMINISTRATION

    Apply to the affected area 3-4 times daily.

     ADVERSE DRUG REACTIONS

    Nausea, abdominal pain, vomiting, diarrhoea, flatulence, elevated liver function values, headache, rashes, exfoliative dermatitis.

     PRECAUTIONS

    The use of topical antibiotics occasionally allows overgrowth of nonsusceptible organisms, including fungi. If this occurs, or if irritation, sensitization, or superinfection develops, treatment with Gentamicin Sulfate should be discontinued and appropriate therapy instituted.

     DRUG INTERACTIONS

    Synergistic with ampicillin, benzylpenicillin and other β-lactam antibiotics. Increased risk of severe respiratory depression when used concurrently with anaesthetics or opioids.

    Potentially Fatal: Increased incidence of ototoxicity when combined with ethacrynic acid and furosemide. Cephalosporins, ciclosporin, cisplatin, vancomycin, hydrocortisone and indomethacin potentiate nephrotoxicity. Potentiates neuromuscular blocking agents.

     CONTRAINDICATIONS

    Contraindicated in individuals with a history of sensitivity to any of its components.

     

     PRESENTATION

    GENTIME: Each tube contains 10g cream